Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohsin Shafiq

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Extracellular Vesicles|November 7, 2024
Efficient enzyme-free isolation of brain-derived extracellular vesiclesAndreu Matamoros-Angles, Emina Karadjuzovic, Behnam Mohammadi, et al.
Acta Neuropathologica|July 15, 2023
Vagus nerve inflammation contributes to dysautonomia in COVID-19Marcel S Woo, Mohsin Shafiq, Antonia Fitzek, et al.
Science Advances|November 24, 2021
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathiesLuise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Extracellular Vesicles|November 7, 2024
Efficient enzyme-free isolation of brain-derived extracellular vesiclesAndreu Matamoros-Angles, Emina Karadjuzovic, Behnam Mohammadi, et al.
Acta Neuropathologica|July 15, 2023
Vagus nerve inflammation contributes to dysautonomia in COVID-19Marcel S Woo, Mohsin Shafiq, Antonia Fitzek, et al.
Science Advances|November 24, 2021
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathiesLuise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Pageof 3